American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Hudis
    Hudis
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Norton
    Norton
  8. Patil
    Patil
  9. Wolchok
    Wolchok
  10. Morris
    Morris

Groups

  1. Solid Tumor Oncology Division (2129)
  2. Genitourinary Disease Management Team (892)
  3. Surgery (840)
  4. Survivorship Research (749)
  5. Genitourinary Oncology Service (697)
  6. Gastrointestinal Disease Management Team (648)
  7. Epidemiology and Biostatistics (619)
  8. Population Sciences Research Program (617)
  9. Breast Cancer Disease Management Team (616)
  10. Thoracic Malignancies Disease Management Team (564)
Search Within
Refine Results
Formats
  1. Meeting Abstract (2080)
  2. Journal Article (1825)
  3. Conference Paper (1)
Groups
  1. Solid Tumor Oncology Division (2129)
  2. Genitourinary Disease Management Team (892)
  3. Surgery (840)
  4. Survivorship Research (749)
  5. Genitourinary Oncology Service (697)
  6. Gastrointestinal Disease Management Team (648)

More Groups

People
  1. Robert Motzer (206)
  2. Howard Scher (201)
  3. Clifford Hudis (198)
  4. Leonard Saltz (173)
  5. Dean Bajorin (146)
  6. Mark Kris (140)

More People

Years
  1. 2018 (231)
  2. 2017 (114)
  3. 2016 (216)
  4. 2015 (508)
  5. 2014 (446)
  6. 2013 (386)

More Years

Publications
  1. Journal of Clinical Oncology (3715)
  2. Journal of Oncology Practice (100)
  3. American Society of Clinical Oncology Educational Book (88)
  4. ASCO Connection (1)
  5. ASCO News & Forum (1)
  6. Impact of subspecially, clinical volume, and years of practice in selection of treatment sequencing in the management of localized extremity soft tissue sarcoma (1)

Results (3906)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pan-cancer microsatellite instability to predict for presence of Lynch syndrome
    Meeting Abstract

    Latham Schwark, A.; Srinivasan, P.; Kemel, Y.; Shia, J.; Bandlamudi, C.; Mandelker, D.; Dubard-Gault, M.; Tran, C.; Middha, S.; Hechtman, J. F.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase III study of taselisib (GDC-0032) + fulvestrant (FULV) v FULV in patients (pts) with estrogen receptor (ER)-positive, PIK3CA-mutant (MUT), locally advanced or metastatic breast cancer (MBC): Primary analysis from SANDPIPER
    Meeting Abstract

    Baselga, J.; Dent, S. F.; Cortés, J.; Im, Y. H.; Diéras, V.; Harbeck, N.; Krop, I. E.; Verma, S.; Wilson, T. R.; Jin, H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Overall survival between African-American (AA) and Caucasian (C) men with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Halabi, S.; Dutta, S.; Tangen, C. M.; Rosenthal, M.; Petrylak, D. P.; Thompson, I. M.; Chi, K. N.; De Bono, J. S.; Fandi, A.; Araujo, J. C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Initial results of a dose escalation study of a selective and structurally differentiated PI3K delta inhibitor, ME-401, in relapsed/refractory (R/R) follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)
    Meeting Abstract

    Soumerai, J. D.; Pagel, J. M.; Jagadeesh, D.; Salman, H. S.; Kenkre, V. P.; Asch, A. S.; Stathis, A.; Reddy, N. M.; Iasonos, A.; Ghalie, R.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • In silico evaluation of the 12-gene molecular score (EndoPredict) and the recurrence score (Oncotype DX) as predictors of response to neo-adjuvant chemotherapy in estrogen receptor positive (ER+), HER2 negative (HER2-) breast cancer
    Meeting Abstract

    Soliman, H. H.; Robson, M. E.; Wagner, S.; Flake, D. D.; Schwartzberg, L. S.; Sharma, P.; Magliocco, A. M.; Kronenwett, R.; Lancaster, J. M.; Lanchbury, J. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Randomized phase 2 trial of polatuzumab vedotin (pola) with bendamustine and rituximab (BR) in relapsed/refractory (r/r) FL and DLBCL
    Meeting Abstract

    Sehn, L. H.; Kamdar, M.; Herrera, A. F.; McMillan, A.; Flowers, C.; Kim, W. S.; Kim, T. M.; Özcan, M.; Demeter, J.; Hertzberg, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • AGILE: A phase 3, multicenter, randomized, placebo-controlled study of ivosidenib in combination with azacitidine in adult patients with previously untreated acute myeloid leukemia with an IDH1 mutation
    Meeting Abstract

    Stein, E.; Dinardo, C. D.; Jang, J. H.; Miyazaki, Y.; Martinez, R. O.; Auer, J.; Zhang, V.; Koralek, D. O.; Wu, B.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase 1 study of NY-ESO-1 vaccine + ipilimumab (IPI) in patients with unresectable or metastatic melanoma
    Meeting Abstract

    Slingluff, C. L.; Zarour, H. M.; Postow, M. A.; Friedlander, P. A.; Devoe, C. E.; Smith, K.; Deacon, D.; Macri, M. J.; Ryan, A.; Venhaus, R. R.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Ambulatory cancer care electronic symptom self-reporting (ACCESS) for surgical patients: A randomized controlled trial
    Meeting Abstract

    Stabile, C.; Temple, L. K. F.; Simon, B. A.; Stetson, P. D.; Stein, D.; Vickers, A. J.; Pusic, A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase 2 study to assess the safety and efficacy of umbralisib (TGR-1202) in pts with CLL who are intolerant to prior BTK or PI3Kδ inhibitor therapy
    Meeting Abstract

    Mato, A. R.; Schuster, S. J.; Lamanna, N.; Flinn, I.; Barrientos, J. C.; Kambhampati, S.; Cheson, B. D.; Barr, P. M.; Pagel, J. M.; Reeves, J. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save